Literature DB >> 15162526

Expression of cytochrome P4502E1 gene in hepatocellular carcinoma.

Xiao-Bo Man1, Liang Tang, Xiu-Hua Qiu, Li-Qun Yang, Hui-Fang Cao, Meng-Chao Wu, Hong-Yang Wang.   

Abstract

AIM: To investigate cytochrome P4502E1 (CYP2E1) gene expression in occurrence and progression of hepatocellular carcinoma (HCC).
METHODS: The human liver arrayed library was spotted onto the nylon membranes to make cDNA array. Hybridization of cDNA array was performed with labeled probes synthesized from RNA isolated from HCC and adjacent liver tissues. Sprague-Dawley rats were administrated diethylnitrosamine (DENA) to induce HCC. CYP2E1 expression was detected by the method of RT-PCR and Northern blot analysis.
RESULTS: CYP2E1 was found by cDNA array hybridization to express differently between HCC and liver tissues. CYP2E1 only expressed in liver, but did not express in HCC tissues and expressed lowly in cirrhotic tissues. In the progression of cirrhosis and HCC, the expression level of CYP2E1 was gradually decreased and hardly detected until the late stage of HCC.
CONCLUSION: Using arrayed library to make cDNA arrays is an effective method to find differential expression genes. CYP2E1 is a unique gene expressing in liver but did not express in HCC. CYP2E1 expression descended along with the initiation and progression of HCC, which is noteworthy further investigations in its significance in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162526      PMCID: PMC4572755          DOI: 10.3748/wjg.v10.i11.1565

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Gene expression in diagnosis.

Authors:  A Berns
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

2.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Authors:  N A Wong; F Rae; K J Simpson; G D Murray; D J Harrison
Journal:  Mol Pathol       Date:  2000-04

Review 3.  Hepatocellular carcinoma: present status and future prospects.

Authors:  Josep M Llovet; Michel Beaugrand
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

4.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 5.  Molecular interactions on microarrays.

Authors:  E Southern; K Mir; M Shchepinov
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

6.  Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.

Authors:  Joerg F Schlaak; Catharien M U Hilkens; Ana P Costa-Pereira; Birgit Strobl; Fritz Aberger; Anna-Maria Frischauf; Ian M Kerr
Journal:  J Biol Chem       Date:  2002-10-16       Impact factor: 5.157

Review 7.  Epidemiological characteristics and risk factors of hepatocellular carcinoma.

Authors:  C J Chen; M W Yu; Y F Liaw
Journal:  J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 4.029

Review 8.  Cytochrome P450 2E1: its clinical and toxicological role.

Authors:  E Tanaka; M Terada; S Misawa
Journal:  J Clin Pharm Ther       Date:  2000-06       Impact factor: 2.512

9.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

Review 10.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02
View more
  7 in total

1.  Liver cancer-related gene CYP2E1 expression in HBV transgenic mice with acute liver injury.

Authors:  Chun Zhang; Qin Wei; Tao Jiang; Xi Shou; Zhi-Qiang Li; Hao Wen
Journal:  Tumour Biol       Date:  2013-12-08

2.  Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology.

Authors:  Jijia Sun; Tao Han; Tao Yang; Yunhui Chen; Jihan Huang
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

3.  HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells.

Authors:  Hongming Liu; Guiyu Lou; Chongyi Li; Xiaodong Wang; Arthur I Cederbaum; Lixia Gan; Bin Xie
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

4.  Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.

Authors:  Gang Liu; Chuanpeng Dong; Lei Liu
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

5.  A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.

Authors:  Torsten Diesinger; Alfred Lautwein; Sebastian Bergler; Dominik Buckert; Christian Renz; Radovan Dvorsky; Vyacheslav Buko; Siarhei Kirko; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Felicitas Genze; Berthold Büchele; Thomas Simmet; Martin Haslbeck; Kai Masur; Thomas Barth; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Journal:  Can J Gastroenterol Hepatol       Date:  2021-02-02

6.  Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas.

Authors:  Liguo Ye; Yang Xu; Long Wang; Chunyu Zhang; Ping Hu; Shi'ao Tong; Zhennan Liu; Daofeng Tian
Journal:  Cancer Med       Date:  2021-10-06       Impact factor: 4.452

7.  CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.

Authors:  Lili Zhu; Xiaobei Yang; Jingyu Feng; Jian Mao; Qidong Zhang; Mengru He; Yang Mi; Yingwu Mei; Ge Jin; Haifeng Zhang
Journal:  J Transl Med       Date:  2022-05-04       Impact factor: 8.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.